The University of Chicago Header Logo

Connection

Mitchell C. Posner to Viremia

Back to Details
This is a "connection" page, showing publications Mitchell C. Posner has written about Viremia.
Mitchell C. Posner
Connection Strength
0.012
Viremia
  1. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol. 2001 Jan 15; 19(2):289-98.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.